Asia-Pacific Skin Graft Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Autologous, Allogeneic, Xenogeneic, Prosthetic, and Isogeneic), Graft Thickness (Split-Thickness, Full-Thickness, and Composite Graft), Application (Burns, Extensive Wound, Skin Cancer, and Other Applications), Equipment (Dermatome, General Surgical Instruments, Consumables, and Others), and End User (Ambulatory Surgical Centers, Hospitals, and Dermatology Clinics)
Market Introduction
Asia Pacific Skin Graft market comprises China, India, Japan, South Korea, Australia, and rest of Asia Pacific. In China, the growth of the market is attributed to rise in the number of cancer cases, rising emphasis on skin protection and development of new technologies for treatment of cancer. As per the report published in 2015, by American Cancer Society, in China, 4.3 million new cancer cases were diagnosed and more than 2.8 million deaths. Rising incidence of cancer has become one of the major economic concern for the country. On the other hand, growing geriatric population is expected to serve vital growth opportunities in coming year. The group of geriatric people are likely to diagnose with diabetes, and other wound through surgeries, fall downs and trauma and more. Among all these factors, diabetes is the primary factor leading to the maximum of diabetic foot ulcer. According to the International Diabetes Federation 2017, ~120 million people had diabetes in China. Additionally, according to the WHO, the diabetic population in China is expected to rise approximately 150 million by 2040. Moreover, the research studies and surveys reveal that in China, the average cost of hospitalization for diabetic foot ulcers (DFUs) is about US$ 2499.02 (i.e., 17,183 yuan). Thus, owing to the increasing incidences of diabetes, and increasing expenses to treat diabetic foot ulcer is likely to serve excellent growth opportunities for the market’s growth
The outbreak of the COVID-19 pandemic has come from China. The spread of infection has affected various Asian countries such as India, South Korea, Australia, Malaysia, Singapore, and others. The countries have reported maximum deaths and laboratory diagnosed positive patients. Amid the second wave of COVID-19, India is experiencing the highest number of cases with lack of healthcare infrastructure. Therefore, various businesses and economies have dramatically affected, resulting in crises. The major focus has been shifted to treat COVID-19 affected patients and the production of personal equipment products. On the other hand, Asian countries have a maximum number of burn cases. Countries such as India, Nepal, and Pakistan have ~ 1 million cases for burn wounds. According to the WHO, an estimated 180 000 deaths every year are caused by burns – the vast majority occur in low- and middle-income countries. In addition, in India, the State-run Victoria hospital affiliated to the Bangalore Medical College and Research Institute (BMCRI) was converted into a dedicated COVID-19 facility ever since the pandemic hit Karnataka in March, the functioning of the Mahabodhi Burns Ward in the hospital has not been hit. Despite the pandemic, the hospital continued to operate normally, following all COVID-19 precautions. With only one skin donation, the hospital was able to graft patches of skin from the patients themselves. Therefore, the outbreak of the COVID-19 pandemic is estimated to affect skin grafts negatively. It is estimated that it will continue to affect negatively in the coming few years.
Get more information on this report :
Market Overview and Dynamics
The skin graft market in APAC is expected to grow from US$ 181.81 million in 2021 to US$ 316.80 million by 2028; it is estimated to grow at a CAGR of 8.3% from 2021 to 2028. Surge in number of burn injuries; major application areas of skin grafts include burns and skin infections. There has been a rise in the number of burns and deaths caused due to burns. Similarly, according to the World Health Organization (WHO) statistics published in 2018, more than 180,000 deaths occurred due to burns. Most burns are reported from low or medium-income countries and Southeast Asia. With the rise in number of burn injuries, the demand for skin grafts to replace the damaged skin patch has increased during recent years. As per the National Burn Repository (NBR) statistics, in 2016, around 486,000 burn injuries received medical treatment. Over 60% of the hospitalizations related to burn injuries were admitted to 128 burn centers. Also, the cost of treatment has increased worldwide. Thus, the increasing number of injuries has contributed significantly to the growing demand for skin graft treatments, which is expected to continue during the forecast period leveraging the market’s growth.
Key Market Segments
Based on product, the market is segmented into autologous, allogeneic, xenogeneic, prosthetic, and isogeneic. In 2020, the autologous segment held the largest share of the market. Based on graft thickness, the market is divided into split-thickness, full-thickness and composite graft. In 2020, the split thickness segment held the largest share of the market. Based on equipment, the market is segmented into dermatome, general surgical instruments, consumables, and others. In 2020, the dermatome segment held the largest share of the market. Based on application, the market is segmented into burns, extensive wound, skin cancer, and others. In 2020, the burns segment held the largest share of the market. Based on end user, the market is segmented into ambulatory surgical centers, hospitals and dermatology clinics. In 2020, the hospitals segment held the largest share of the market.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the skin graft market in APAC are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are B. Braun Melsungen AG; Integra Life Sciences Corporation; MiMedx; Organogenesis Inc; Smith & Nephew; Zimmer Biomet.
Reasons to buy report
- To understand the APAC skin graft market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for APAC Skin Graft Market
- Efficiently plan M&A and partnership deals in APAC skin graft market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form APAC skin graft market
- Obtain market revenue forecast for market by various segments from 2021-2028 in APAC region.
APAC SKIN GRAFT MARKET SEGMENTATION
By Product
- Autologous
- Allogeneic
- Xenogeneic
- Prosthetic
- Isogeneic
By Graft Thickness
- Split-Thickness
- Full-Thickness
- Composite Graft
By Equipment
- Dermatome
- General Surgical Instruments
- Consumables
- Others
By Application
- Burns
- Extensive Wound
- Skin Cancer
- Other Applications
By End User
- Hospitals
- Ambulatory Surgical Centers
- Dermatology Clinics
By Country
- China
- Japan
- India
- South Korea
- Australia
- Rest of APAC
Companies Mentioned
- B. Braun Melsungen AG
- Integra Life Sciences Corporation
- MiMedx
- Organogenesis Inc
- Smith & Nephew
- Zimmer Biomet
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Skin Graft Market – By Product
1.3.2 APAC Skin Graft Market – By Graft Thickness
1.3.3 APAC Skin Graft Market – By Equipment
1.3.4 APAC Skin Graft Market – By Application
1.3.5 APAC Skin Graft Market – By End User
1.3.6 APAC Skin Graft Market– By Country
2. APAC Skin Graft Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Skin Graft– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific PEST Analysis
4.3 Expert Opinion
5. APAC Skin Graft Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Surge in Number of Burn Injuries
5.1.2 Increasing Prevalence of Skin Cancer and Diabetes
5.2 Market Restraints
5.2.1 Rising Cost of Skin Grafting Procedures
5.2.2 Alternatives for Skin Grafts
5.3 Market Opportunities
5.3.1 3D-printed Skin Grafts
5.4 Future Trends
5.4.1 Research Activities and Product Innovations
5.5 Impact Analysis
6. Skin Graft Market – APAC Analysis
6.1 APAC Skin graft Market Revenue Forecast and Analysis
7. APAC Skin Graft Market Analysis – By Product
7.1 Overview
7.2 APAC Skin Graft Market Revenue Share, by Product (2020 and 2028)
7.3 Autologous
7.3.1 Overview
7.3.2 Autologous: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Allogeneic
7.4.1 Overview
7.4.2 Allogeneic: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
7.5 Xenogeneic
7.5.1 Overview
7.5.2 Xenogeneic: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
7.6 Prosthetic
7.6.1 Overview
7.6.2 Prosthetic: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
7.7 Isogeneic Grafts
7.7.1 Overview
7.7.2 Isogeneic Grafts: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
8. APAC Skin Graft Market Analysis – By Graft Thickness
8.1 Overview
8.2 APAC Skin Graft Market Revenue Share, by Graft Thickness (2020 and 2028)
8.3 Split Thickness
8.3.1 Overview
8.3.2 Split Thickness: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Full-Thickness Skin Grafts
8.4.1 Overview
8.4.2 Full-Thickness Skin Grafts: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
8.5 Composite Graft
8.5.1 Overview
8.5.2 Composite Graft: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
9. APAC Skin Graft Market Analysis – By Equipment
9.1 Overview
9.2 APAC Skin Graft Market Revenue Share, by Equipment (2020 and 2028)
9.3 Dermatome
9.3.1 Overview
9.3.2 Dermatome: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
9.4 General Surgical Instruments
9.4.1 Overview
9.4.2 General Surgical Instruments: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
9.5 Consumables
9.5.1 Overview
9.5.2 Consumables: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
10. APAC Skin Graft Market Analysis – By Application
10.1 Overview
10.2 APAC Skin Graft Market Revenue Share, by Application (2020 and 2028)
10.3 Burns
10.3.1 Overview
10.3.2 Burns: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
10.4 Extensive Wound
10.4.1 Overview
10.4.2 Extensive Wound: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
10.5 Skin Cancer
10.5.1 Overview
10.5.2 Skin Cancer: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
10.6 Other Applications
10.6.1 Overview
10.6.2 Other Applications: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
11. APAC Skin Graft Market– By End User
11.1 Overview
11.2 Skin Graft Market Revenue Share, by End User (2020 and 2028)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
11.4 Ambulatory Surgical Centers
11.4.1 Overview
11.4.2 Ambulatory Surgical Centers: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
11.5 Dermatology Clinics
11.5.1 Overview
11.5.2 Dermatology Clinics: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
12. APAC Skin Graft Market – Country Analysis
12.1 Asia Pacific
12.1.1 Overview
12.1.2 Asia Pacific: Skin Graft Market, by Country, 2020 & 2028 (%)
12.1.2.1 China: Skin Graft Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.1.1 China: Skin Graft Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.1.2 China: Skin Graft Market, by Product, 2019–2028 (USD Million)
12.1.2.1.3 China: Skin Graft Market, by Graft Thickness, 2019–2028 (USD Million)
12.1.2.1.4 China: Skin Graft Market, by Application, 2019–2028 (Million)
12.1.2.1.5 China: Skin Graft Market, by Equipment, 2019–2028 (Million)
12.1.2.1.6 China: Skin Graft Market, by End User, 2019–2028 (USD Million)
12.1.2.2 Japan: Skin Graft Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.1 Japan: Skin Graft Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.2 Japan: Skin Graft Market, by Product, 2019–2028 (USD Million)
12.1.2.2.3 Japan: Skin Graft Market, by Graft Thickness, 2019–2028 (USD Million)
12.1.2.2.4 Japan: Skin Graft Market, by Application, 2019–2028 (Million)
12.1.2.2.5 Japan: Skin Graft Market, by Equipment, 2019–2028 (Million)
12.1.2.2.6 Japan: Skin Graft Market, by End User, 2019–2028 (USD Million)
12.1.2.3 India: Skin Graft Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.3.1 India: Skin Graft Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.3.2 India: Skin Graft Market, by Product, 2019–2028 (USD Million)
12.1.2.3.3 India: Skin Graft Market, by Graft Thickness, 2019–2028 (USD Million)
12.1.2.3.4 India: Skin Graft Market, by Application, 2019–2028 (Million)
12.1.2.3.5 India: Skin Graft Market, by Equipment, 2019–2028 (Million)
12.1.2.3.6 India: Skin Graft Market, by End User, 2019–2028 (USD Million)
12.1.2.4 South Korea: Skin Graft Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.4.1 South Korea: Skin Graft Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.4.2 South Korea: Skin Graft Market, by Product, 2019–2028 (USD Million)
12.1.2.4.3 South Korea: Skin Graft Market, by Graft Thickness, 2019–2028 (USD Million)
12.1.2.4.4 South Korea: Skin Graft Market, by Application, 2019–2028 (Million)
12.1.2.4.5 South Korea: Skin Graft Market, by Equipment, 2019–2028 (Million)
12.1.2.4.6 South Korea: Skin Graft Market, by End User, 2019–2028 (USD Million)
12.1.2.5 Australia: Skin Graft Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.5.1 Australia: Skin Graft Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.5.2 Australia: Skin Graft Market, by Product, 2019–2028 (USD Million)
12.1.2.5.3 Australia: Skin Graft Market, by Graft Thickness, 2019–2028 (USD Million)
12.1.2.5.4 Australia: Skin Graft Market, by Application, 2019–2028 (Million)
12.1.2.5.5 Australia: Skin Graft Market, by Equipment, 2019–2028 (Million)
12.1.2.5.6 Australia: Skin Graft Market, by End User, 2019–2028 (USD Million)
12.1.2.6 Rest of Asia Pacific: Skin Graft Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.6.1 Rest of Asia Pacific: Skin Graft Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.6.2 Rest of Asia Pacific: Skin Graft Market, by Product, 2019–2028 (USD Million)
12.1.2.6.3 Rest of Asia Pacific: Skin Graft Market, by Graft Thickness, 2019–2028 (USD Million)
12.1.2.6.4 Rest of Asia Pacific: Skin Graft Market, by Application, 2019–2028 (Million)
12.1.2.6.5 Rest of Asia Pacific: Skin Graft Market, by Equipment, 2019–2028 (Million)
12.1.2.6.6 Rest of Asia Pacific: Skin Graft Market, by End User, 2019–2028 (USD Million)
13. Impact of COVID-19 Pandemic on APAC Skin graft Market
13.1 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
14. Skin Graft Market– Industry Landscape
14.1 Overview
14.2 Organic Developments
14.2.1 Overview
14.3 Inorganic Developments
14.3.1 Overview
15. Company Profiles
15.1 B. Braun Melsungen AG
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Integra Life Sciences Corporation
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Smith & Nephew
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 MiMedx
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Organogenesis Inc.
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Zimmer Biomet
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
16. Appendix
16.1 About the Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. APAC Skin graft Market, Revenue and Forecast to 2028 (USD Million)
Table 2. China: Skin Graft Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 3. China: Skin Graft Market, by Graft Thickness– Revenue and Forecast to 2028 (USD Million)
Table 4. China: Skin Graft Market, by Application– Revenue and Forecast to 2028 (Million)
Table 5. China: Skin Graft Market, by Equipment – Revenue and Forecast to 2028 (Million)
Table 6. China: Skin Graft Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan: Skin Graft Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 8. Japan: Skin Graft Market, by Graft Thickness– Revenue and Forecast to 2028 (USD Million)
Table 9. Japan: Skin Graft Market, by Application– Revenue and Forecast to 2028 (Million)
Table 10. Japan: Skin Graft Market, by Equipment – Revenue and Forecast to 2028 (Million)
Table 11. Japan: Skin Graft Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 12. India: Skin Graft Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 13. India: Skin Graft Market, by Graft Thickness– Revenue and Forecast to 2028 (USD Million)
Table 14. India: Skin Graft Market, by Application– Revenue and Forecast to 2028 (Million)
Table 15. India: Skin Graft Market, by Equipment – Revenue and Forecast to 2028 (Million)
Table 16. India: Skin Graft Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. South Korea: Skin Graft Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 18. South Korea: Skin Graft Market, by Graft Thickness– Revenue and Forecast to 2028 (USD Million)
Table 19. South Korea: Skin Graft Market, by Application– Revenue and Forecast to 2028 (Million)
Table 20. South Korea: Skin Graft Market, by Equipment – Revenue and Forecast to 2028 (Million)
Table 21. South Korea: Skin Graft Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 22. Australia: Skin Graft Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 23. Australia: Skin Graft Market, by Graft Thickness– Revenue and Forecast to 2028 (USD Million)
Table 24. Australia: Skin Graft Market, by Application– Revenue and Forecast to 2028 (Million)
Table 25. Australia: Skin Graft Market, by Equipment – Revenue and Forecast to 2028 (Million)
Table 26. Australia: Skin Graft Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 27. Rest of Asia Pacific: Skin Graft Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 28. Rest of Asia Pacific: Skin Graft Market, by Graft Thickness– Revenue and Forecast to 2028 (USD Million)
Table 29. Rest of Asia Pacific: Skin Graft Market, by Application– Revenue and Forecast to 2028 (Million)
Table 30. Rest of Asia Pacific: Skin Graft Market, by Equipment – Revenue and Forecast to 2028 (Million)
Table 31. Rest of Asia Pacific: Skin Graft Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 32. Organic Developments Done By Companies
Table 33. Inorganic Developments Done By Companies
Table 34. Glossary of Terms, APAC Skin Graft Market
LIST OF FIGURES
Figure 1. APAC Skin Graft Market Segmentation
Figure 2. APAC Skin Graft Segmentation, By Country
Figure 3. APAC Skin Graft Market Overview
Figure 4. Autologous Segment Held Largest Share of APAC Skin Graft Market
Figure 5. China to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Expert Opinion
Figure 8. APAC Skin Graft Market Impact Analysis of Drivers and Restraints
Figure 9. APAC Skin graft Market – Revenue Forecast and Analysis – 2020- 2028
Figure 10. APAC Skin Graft Market Revenue Share, by Product (2020 and 2028)
Figure 11. Autologous: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. Allogeneic: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. Xenogeneic: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. Prosthetic: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Isogeneic Grafts: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. APAC Skin Graft Market Revenue Share, by Graft Thickness (2020 and 2028)
Figure 17. Split Thickness: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. Full-Thickness Skin Grafts: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19. Composite Graft: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. APAC Skin Graft Market Revenue Share, by Equipment (2020 and 2028)
Figure 21. Dermatome: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
Figure 22. General Surgical Instruments: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
Figure 23. Consumables: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
Figure 25. APAC Skin Graft Market Revenue Share, by Application (2020 and 2028)
Figure 26. Burns: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
Figure 27. Extensive Wound: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
Figure 28. Skin Cancer: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
Figure 29. Other Application: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
Figure 30. Skin Graft Market Revenue Share, by End User (2020 and 2028)
Figure 31. Hospitals: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. Ambulatory Surgical Centers: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
Figure 33. Dermatology Clinics: APAC Skin Graft Market– Revenue and Forecast to 2028 (US$ Million)
Figure 34. APAC: Skin Graft Market, by Key Country – Revenue (2020) (USD Million)
Figure 35. Asia Pacific: Skin Graft Market, by Country, 2020 & 2028 (%)
Figure 36. China: Skin Graft Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Japan: Skin Graft Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. India: Skin Graft Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. South Korea: Skin Graft Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Australia: Skin Graft Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. Rest of Asia Pacific: Skin Graft Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- B. Braun Melsungen AG
- Integra Life Sciences Corporation
- MiMedx
- Organogenesis Inc
- Smith & Nephew
- Zimmer Biomet
- To understand the APAC skin graft market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for APAC Skin Graft Market
- Efficiently plan M&A and partnership deals in APAC skin graft market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form APAC skin graft market
- Obtain market revenue forecast for market by various segments from 2021-2028 in APAC region.